Yes, I think that's important because now there's a huge set of studies that are showing that in fact for that tiny group, if they don't get diacetylmorphine or hydromorphone, which is Dilaudid, they will go onto street drugs again. So that's one way of stopping them getting back into that street drug system. I'm glad you think that evidence should work in some of these things.
I wanted to talk about the idea—and I don't know who should answer. Mr. Chair, you might want to direct that to whoever should answer it—you talked about the First Do No Harm program. Does that mean that you think that harm reduction is an important piece, if First Do No Harm is the obvious medical ethic? Who wants to answer that?
I noticed that no one had harm reduction as part of their comprehensive package of looking at substance abuse and at looking at decreasing the amount. Who wants to...?
Mr. Chair, who wants to take the First Do No Harm and tell me why there is no harm reduction in your programs?